8.00 AM
9.00 AM
Registration Opens & Morning Refreshments
9.00 AM
9.05 AM
Welcome
Katie Gordon, MC, Ignite Partners
9.05 AM
9.50 AM
Investment Leaders Panel: Commodities Supercycle, Here to Stay?
Supercycle or Short Surge: Resource nationalism, decarbonization and inflation in commodities
Minerals in Focus: Shining a spotlight on the key resources shaping tomorrow
Capital Allocation: With capital flooding commodities, how should investors time entry and manage risk in today’s volatile market?
Equity vs Physical: Debating the resilience of mining equities, ETFs, and royalty companies versus direct commodity holdings and infrastructure
Moderator
Damian Pearson, Partner, Oryx Global Partners & Vice Chairman of the Asia Mining Club
Speakers
Michelle Leung, Head of Asia Metals and Mining, Sustainability, Bloomberg
Jimmy Lim, Managing Director, Grant Samuel
Louis Wong, Analyst, Gold Mountains Asset Management
Samson Li, Analyst, Commodity Discovery Fund
9.50 AM
11.00 AM
CEO Presentations
9.50 AM NexGen Energy
10.00 AM Jade Gas
10.10 AM Ecora Royalties
10.20 AM Scottie Resources
10.30 AM Silver Tiger Metals
10.40 AM Cobre
10.50 AM Sky Metals
11.00 AM
11.40 AM
Inside Family Offices: Approaches to Direct Equity & Stock Selection
Direct Equity Entry Points: How family offices evaluate opportunities in resource companies and individual stocks
Risk & Governance: Balancing preservation with risk management in unpredictable commodity markets
Sector Perspectives: Mining and commodities as diversification tools and inflation hedges in family portfolios
Speakers
Jean-Sébastien Jacquetin, Managing Partner, Cavendish
Christopher Chan, Portfolio Manager, Topaz Family Office
11.40 AM
1.00 PM
CEO Presentations
11.40 AM Rio De Oro
11.50 AM Aventine Resources
12.00 PM Kaoko Metals
12.10 PM Red Mountain Mining
12.20 PM Sunstone Metals
12.30 PM Kingfisher Metals
12.40 PM Horizon Gold
12.50 PM Miata Metals
1.00 PM
2.00 PM
Lunch
2.00 PM
2.40 PM
Life Sciences in Asia: From Local Growth to Global Leadership
Investor Attributes 2026 – 27: How global and Asia based investors are redefining what they look for in small cap life sciences
Capital Priorities: The rise of family offices, sovereign funds, and cross border money movement reshaping Asia’s life sciences funding landscape and setting new benchmarks for growth
Global Integration or Lone Wolf? Will APAC life sciences firms remain regionally focused, or will they expand partnerships and leadership roles to embed themselves in global markets?
Moderator
Matthew Cheng, Senior Advisor, Hua Medicine
Speakers
Angus Walker, Chief Investment Officer, MWP Partners
Dr Charles Hu, CEO, Ryoden Medical Holdings (Ryoden Development Limited)
Da Liu, Managing Director, CR-CP Life Science Fund
2.40 PM
5.00 PM
CEO Presentations
2.40 PM Recce Pharmaceuticals
2.50 PM Dimerix
3.00 PM Paradigm Biopharma
3.10 PM First Graphene
3.20 PM Pure One
3.30 PM Yukon Metals
3.40 PM STLLR Gold
3.50 PM Pilbara Gold
4.00 PM Latitude 66
4.10 PM Nordic Resources
4.20 PM Kalgoorlie Gold Mining
4.30 PM 1911 Gold
4.40 PM Ore Resources
4.50 PM MetalsGrove
